◆ Listed stock · NOVN.SW
Novartis
Laboratoire pharmaceutique suisse. Cotée sur Zurich · SIX.
◆ Live market
…
24h
—
- Ticker
- NOVN.SW
- Category
- Stocks & ETFs
- Type
- Listed stock
- Group
- Zurich · SIX
- Trading hours
- Market sessions
What is Novartis?
Laboratoire pharmaceutique suisse. Cotée sur Zurich · SIX. A share represents part ownership of a listed company. Its price reflects investors' expectations of future earnings.
How Novartis works and what gives it value
The stock reacts to quarterly results, management guidance, sector news and the rate backdrop. Earnings releases often cause big opening gaps.
What moves the price of Novartis
- ◆Earnings and guidance
- ◆Interest rates
- ◆Sector news
- ◆Buybacks and dividends
Key metrics to watch
- ◆Revenue growth
- ◆Margins
- ◆P/E ratio
- ◆Earnings dates
Risks specific to Novartis
- ◆Earnings disappointments
- ◆High valuation
- ◆Regulatory risk
How to analyse Novartis on GraphTrade
Daily and weekly; market open only during sessions. Open the NOVN.SW chart, add the indicators below, compare Novartis with similar assets in Performance and ask the AI Compass to explain the latest move with news and macro context.
Themes
Included in: Zurich · SIX.
◆ Indicators suited to Novartis
◆ FAQ
What is Novartis (NOVN.SW)?
Laboratoire pharmaceutique suisse. Cotée sur Zurich · SIX.
Why is Novartis going up or down today?
The main drivers are: earnings and guidance, interest rates, sector news, buybacks and dividends. The AI Compass cross-references these with today's news.
Which indicators work best on Novartis?
Daily and weekly; market open only during sessions.
What are the risks of Novartis?
Earnings disappointments ; High valuation ; Regulatory risk.
How do I follow Novartis in real time?
Open the free GraphTrade chart for NOVN.SW: price updates live, with all indicators.
How do I add Novartis to my portfolio?
Click « Add to portfolio » on this page: the asset joins your active portfolio.
Is this investment advice?
No. GraphTrade provides information and analysis tools only.
◆ Assets similar to Novartis
Information only, not investment advice.